Search - tctmd.com

Displaying 181 - 200 of 416

Sort: Relevancy | Date

News Opinion Editor's Corner ACC 2023

What’s Going to Be Hot at ACC/WCC 2023?

Shelley Wood

February 27, 2023

News Opinion CV Team Dispatch

February 2023 News Roundup

L.A. McKeown

February 15, 2023

News Daily News

Acute Cardiac Events More Common in COVID-19 Patients With Heart Histories

Caitlin E. Cox

February 10, 2023

News Daily News

Vast Majority of HFrEF Patients Eligible for Vericiguat

L.A. McKeown

February 08, 2023

News Daily News

For Some, Hopes for a Heart Grow Dim as LVAD-Only Centers Spread

Michael O'Riordan

January 30, 2023

News Daily News

New IABP Recall: Balloon Catheter Damage Might Cause Bleeding Into Pump

Shelley Wood

January 25, 2023

News Daily News

Angioedema Risk No Higher With ARNI Than With ACE Inhibitors, ARBs

Todd Neale

January 23, 2023

News Daily News

HFrEF’s Financial Burden May Get Relief From Inflation Reduction Act

L.A. McKeown

January 13, 2023

News Daily News

Even When Eligible, Not All Acute HF Patients Get GDMT

Todd Neale

January 11, 2023

News Daily News

Top Heart Failure News of 2022

Shelley Wood

January 04, 2023

News Opinion Editor's Corner

The Biggest News of 2022: TCTMD’s Top 10

Shelley Wood

December 30, 2022

News Daily News

FDA Advisors Recommend Against Approval of Omecamtiv Mecarbil

Michael O'Riordan

December 14, 2022

News Daily News

Cardiogenic Shock Outcomes Markedly Worse in De Novo HF Patients

Caitlin E. Cox

December 09, 2022

News Daily News

Analysis Cements Benefits of SGLT2 Inhibitors in HF, but Diabetes Matters for Deaths

Michael O'Riordan

December 08, 2022

News Conference News PCR London Valves 2022

Will Tricuspid Innovation Outpace Mitral? Some Hopes, Some Second-Guessing

Shelley Wood

December 07, 2022

News Industry News

Corvia Medical Announces Randomization of First Patient in the RESPONDER-HF Confirmatory Trial

December 06, 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2022

Caitlin E. Cox

December 01, 2022

News Conference News AHA 2022

CRISPR/Cas-9 Gene Editing Shows Promise in Transthyretin Amyloidosis

Yael L. Maxwell

November 05, 2022

News Conference News AHA 2022

TRANSFORM-HF: Torsemide No Better Than Furosemide for Hospitalized HF

Todd Neale

November 05, 2022

News Conference News AHA 2022

Novel Intervention to Increase GDMT in HF Exploits Noncardiac Admissions

Yael L. Maxwell

November 01, 2022

Advertisement

What’s Going to Be Hot at ACC/WCC 2023?

February 2023 News Roundup

Acute Cardiac Events More Common in COVID-19 Patients With Heart Histories

Vast Majority of HFrEF Patients Eligible for Vericiguat

For Some, Hopes for a Heart Grow Dim as LVAD-Only Centers Spread

New IABP Recall: Balloon Catheter Damage Might Cause Bleeding Into Pump

Angioedema Risk No Higher With ARNI Than With ACE Inhibitors, ARBs

HFrEF’s Financial Burden May Get Relief From Inflation Reduction Act

Even When Eligible, Not All Acute HF Patients Get GDMT

Top Heart Failure News of 2022

The Biggest News of 2022: TCTMD’s Top 10

FDA Advisors Recommend Against Approval of Omecamtiv Mecarbil

Cardiogenic Shock Outcomes Markedly Worse in De Novo HF Patients

Analysis Cements Benefits of SGLT2 Inhibitors in HF, but Diabetes Matters for Deaths

Will Tricuspid Innovation Outpace Mitral? Some Hopes, Some Second-Guessing

Corvia Medical Announces Randomization of First Patient in the RESPONDER-HF Confirmatory Trial

TCTMD’s Top 10 Most Popular Stories for November 2022

CRISPR/Cas-9 Gene Editing Shows Promise in Transthyretin Amyloidosis

TRANSFORM-HF: Torsemide No Better Than Furosemide for Hospitalized HF

Novel Intervention to Increase GDMT in HF Exploits Noncardiac Admissions

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content